Areas of uncertainty in the assessment of risks and benefits in applications for new biological control agents submitted to the regulator for proposed introduction into New Zealand were identified. This was done with the aim of informing future research priorities which might be able to address and reduce these areas of uncertainty to assist decision-making in the future.